{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:13Z","timestamp":1788815293512,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.psychres.2026.117394","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:05:30Z","timestamp":1786881930000},"page":"117394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of oxLDL and LOX-1 levels in obsessive-compulsive disorder"],"prefix":"10.1016","volume":"365","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1191-1807","authenticated-orcid":false,"given":"Anil","family":"Mersin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-265X","authenticated-orcid":false,"given":"Mustafa","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Onur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2026.117394_bib0001","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpsychires.2024.07.015","article-title":"Elevated levels of oxLDL and LOX-1: implications for schizophrenia pathophysiology","volume":"177","author":"Akkus","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.psychres.2026.117394_bib0002","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000306591","article-title":"Relationship of stress-related biochemical markers to oxidative status in obsessive-compulsive disorder","volume":"61","author":"Behl","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2026.117394_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5698931","article-title":"Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?","volume":"2016","author":"Biswas","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.psychres.2026.117394_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-036859","article-title":"Neutrophil-lymphocyte ratio across psychiatric diagnoses: a cross-sectional study using electronic health records","volume":"10","author":"Brinn","year":"2020","journal-title":"BMJ Open"},{"issue":"17","key":"10.1016\/j.psychres.2026.117394_bib0005","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1074\/jbc.275.17.12633","article-title":"Oxidized low density lipoprotein binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular superoxide","volume":"275","author":"Cominacini","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"S1","key":"10.1016\/j.psychres.2026.117394_bib0006","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2022.753","article-title":"Inflammatory markers in obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"65","author":"Constable","year":"2022","journal-title":"Eur. Psychiatry."},{"issue":"1","key":"10.1016\/j.psychres.2026.117394_bib0007","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biomedicines10010056","article-title":"Off-target effects of antidepressants on vascular function and structure","volume":"10","author":"Dimoula","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.psychres.2026.117394_bib0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.comppsych.2005.11.006","article-title":"Impact of obsessive-compulsive disorder on quality of life","volume":"47","author":"Eisen","year":"2006","journal-title":"Compr. Psychiatry."},{"key":"10.1016\/j.psychres.2026.117394_bib0009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.intimp.2019.02.013","article-title":"Microglial LOX-1\/MAPKs\/NF-kappaB positive loop promotes the onset of neuroinflammation","volume":"70","author":"Ge","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2026.117394_bib0010","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The yale-brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.psychres.2026.117394_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113065","article-title":"Associations between subclinical inflammatory markers and obsessive-compulsive disorder: a retrospective study","volume":"290","author":"Herdi","year":"2020","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.psychres.2026.117394_bib0012","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/08039488.2021.1896779","article-title":"Relationship between disease severity and semaphorin 5A and hemogram level in patients with obsessive compulsive disorder","volume":"75","author":"Karatas","year":"2021","journal-title":"Nord. J. Psychiatry."},{"issue":"7","key":"10.1016\/j.psychres.2026.117394_bib0013","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/antiox8070218","article-title":"LOX-1: regulation, signaling and its role in atherosclerosis","volume":"8","author":"Kattoor","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.psychres.2026.117394_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/65704","article-title":"Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder","volume":"2007","author":"Konuk","year":"2007","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.psychres.2026.117394_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000063573","article-title":"Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder","volume":"46","author":"Kuloglu","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2026.117394_bib0016","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pnpbp.2012.09.008","article-title":"Oxidative\/nitrosative stress and antidepressants: targets for novel antidepressants","volume":"46","author":"Lee","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"5","key":"10.1016\/j.psychres.2026.117394_bib0017","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/acps.13026","article-title":"Oxidative and nitrosative stress markers in obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"139","author":"Maia","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2026.117394_bib0018","article-title":"Proteolytic regulation of the lectin-like oxidized lipoprotein receptor LOX-1","volume":"7","author":"Mentrup","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.psychres.2026.117394_bib0019","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2147\/NDT.S112374","article-title":"Mean platelet volume in bipolar disorder","volume":"12","author":"Mert","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.psychres.2026.117394_bib0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.ATV.20.3.715","article-title":"Identification of soluble forms of lectin-like oxidized LDL receptor-1","volume":"20","author":"Murase","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117394_bib0021","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2008.10.004","article-title":"Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in OCD patients","volume":"33","author":"Ozdemir","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.psychres.2026.117394_bib0022","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12031-024-02247-x","article-title":"Serum erythropoietin and ischemic-modified albumin levels in adolescents with obsessive-compulsive disorder","volume":"74","author":"\u00d6zt\u00fcrk","year":"2024","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.psychres.2026.117394_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.psychres.2026.117394_bib0024","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.psychres.2015.07.009","article-title":"Plasma cytokine abnormalities in drug-naive OCD","volume":"229","author":"Rao","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117394_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbi.2012.11.011","article-title":"Dysregulated relationship of inflammation and oxidative stress in major depression","volume":"31","author":"Rawdin","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.psychres.2026.117394_bib0026","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of OCD in the NCS-R","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatry."},{"issue":"6","key":"10.1016\/j.psychres.2026.117394_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306125","article-title":"Exploring the role of interleukin-1beta and interleukin-6 in OCD","volume":"19","author":"Sarmin","year":"2024","journal-title":"PLoS One"},{"issue":"6620","key":"10.1016\/j.psychres.2026.117394_bib0028","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/386073a0","article-title":"An endothelial receptor for oxidized low-density lipoprotein","volume":"386","author":"Sawamura","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.psychres.2026.117394_bib0029","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pnpbp.2007.10.002","article-title":"Oxidative imbalance in OCD patients: a total evaluation of oxidant-antioxidant status","volume":"32","author":"Selek","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.psychres.2026.117394_bib0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jad.2025.02.089","article-title":"Exploring the relationship between serum LOX-1, Ox-LDL, and generalized anxiety disorder","volume":"378","author":"Solak","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.psychres.2026.117394_bib0031","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0447.1995.tb09801.x","article-title":"Yale-brown obsessive compulsive scale in Turkish: reliability and validity","volume":"91","author":"Tek","year":"1995","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2026.117394_bib0032","article-title":"The effect of major depressive disorder comorbidity on ischemia-modified albumin levels, a marker of oxidative stress, and antioxidant defense system in patients with obsessive compulsive disorder","volume":"15","author":"Zengil","year":"2024","journal-title":"Front. Psychiatr."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126004543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126004543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:20:12Z","timestamp":1788812412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126004543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"alternative-id":["S0165178126004543"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117394","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of oxLDL and LOX-1 levels in obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117394"}}